FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Syntho Pharmaceuticals Eemt Recall

EEMT (esterified estrogens and methyltestosterone) 1

Syntho Pharmaceuticals, Inc. · Farmingdale, NY

Risk level
Class II
Reported by FDA
Jan 23, 2019
Recall ID
D-0378-2019
Check your lot numberHow we source this data

Summary

Syntho Pharmaceuticals recalled Eemt starting Apr 17, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0378-2019 on Jan 23, 2019. Reason: CGMP deviations: Lots were recalled due to sub-potency and cGMP violations. Status: Terminated.

Why it was recalled

CGMP deviations: Lots were recalled due to sub-potency and cGMP violations.

Product description

EEMT (esterified estrogens and methyltestosterone) 1.25 mg/2.5 mg, tablets,100-count bottle, Rx only, Manufactured By: Syntho Pharmaceuticals, Inc., Farmingdale, NY 11735, Distributed By: Creekwood Pharmaceutical, Inc., Birmingham, AL 35242, NDC 15310-010-01

Lot numbers, UPCs & expiration codes

Lot #: S16E02, Exp 05/18

Where it was sold

Product was sold to the firm's sole distributor who further distributed the product throughout the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0378-2019
Classification
Class II
Status
Terminated
Recall initiated
Apr 17, 2017
FDA report date
Jan 23, 2019
Quantity
5,000 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Syntho Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0378-2019, exactly as published.

Show all FDA fields
City
Farmingdale
State
NY
Status
Terminated
Country
United States
Event ID
81867
Address
230 Sherwood Ave
Code information
Lot #: S16E02, Exp 05/18
Postal code
11735-1718
Report date
Jan 23, 2019
Product type
Drugs
Recall number
D-0378-2019
Classification
Class II
Recalling firm
Syntho Pharmaceuticals, Inc.
Product quantity
5,000 bottles
Termination date
Mar 27, 2020
Reason for recall
CGMP deviations: Lots were recalled due to sub-potency and cGMP violations.
Voluntary / mandated
Voluntary: Firm initiated
Product description
EEMT (esterified estrogens and methyltestosterone) 1.25 mg/2.5 mg, tablets,100-count bottle, Rx only, Manufactured By: Syntho Pharmaceuticals, Inc., Farmingdale, NY 11735, Distributed By: Creekwood Pharmaceutical, Inc., Birmingham, AL 35242, NDC 15310-010-01
Distribution pattern
Product was sold to the firm's sole distributor who further distributed the product throughout the United States.
Recall initiation date
Apr 17, 2017
Initial firm notification
Letter
Center classification date
Jan 16, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0378-2019, published Jan 23, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls